Priority Review Voucher Programs Poised For US Legislative Attention In 2020

 
• By Sue Sutter
  
Priority Fast Lane Sign Airport First Class Luxury Notification Blue Light
US FDA seeks statutory clarity on biologics eligible for priority review vouchers. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards